Creative Details

Quality Score: 7/10

The advertisement promotes CARVYKTI®, a treatment for multiple myeloma, emphasizing the importance of patient advocacy and providing critical safety information regarding potential severe side effects.

Creative Information

CID:0598ca9b-b17d-4ee3-89fc-b131372ecad3
CRID:25_e5txnbrf
Domain:carvykti.com
Seat:TTD
Size:300x600
Bid:$0.47
Timestamp:11/13/2025, 6:50:05 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/13/2025, 8:34:00 PM6.95s
    adomain_analysissuccess11/13/2025, 9:07:42 PM4.50s
    adomain_capturesuccess11/13/2025, 9:05:00 PM0.20s
    ad_rendersuccess11/13/2025, 8:33:53 PM22.02s
    brand_mappingsuccess11/13/2025, 6:50:05 PM0.15s

    Analysis Results

    Ad Format: banner

    Brands: Carvykti

    Sensitive:Pharmaceutical Products
    Size:300x600
    Data Transferred:1485.43 KB
    Render Time:8.45 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Society (IAB14)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Medical and Biotechnology (1043)
    • Health and Medical Services (1378)
    Landing Page:
    https://www.carvykti.com/?utm_source=10072451&utm_...
    Domain:www.carvykti.com
    Brand:
    Carvykti
    Total Ad Size:1504.82 KB
    Requests Made:
    URLSize (KB)
    https://static.adsafeprotected.com/main.19.8.619.js269.79
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js222.95
    https://static.adsafeprotected.com/sca.17.6.4.js182.86
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N2561878.2783400HEALTHUNION.COM/B33407628.417951457;dc_ver=106.314;dc_eid=40004000;sz=300x600;u_sd=1;gdpr=0;nel=1;dc_adk=2027040026;ord=qtete5;click=https%3A%2F%2Finsight.adsrvr.org%2Ftrack%2Fclk%3Fimp%3Dcb9a5347-7f9e-47d5-92d1-e52ad2cf2d3e%26ag%3D4grozau%26sfe%3D1b4ca568%26sig%3Debc-kk637QSeq2gNrN4Ykj8wF1fqZmiDj_oIAWGGOKw.%26crid%3De5txnbrf%26cf%3D9667806%26fq%3D0%26t%3D1%26td_s%3Dmail.aol.com%26rcats%3Doj8%26mste%3D%26mfld%3D2%26mssi%3D%26mfsi%3D%26sv%3Dkargo%26uhow%3D91%26agsa%3D%26wp%3D0.4668279%26rgz%3D17111%26dt%3DPC%26osf%3DWindows%26os%3DWindows10%26br%3DChrome%26svpid%3D8727%26rlangs%3Den%26mlang%3D%26did%3D%26rcxt%3DOther%26tmpc%3D10.840000000000032%26vrtd%3D%26osi%3D%26osv%3D%26daid%3D%26dnr%3D0%26vpb%3D%26crrelr%3D%26npt%3D%26cc%3D2~KLUv_WMdqREMrQMtFwAj4Xi4XFtUbk1Uju2W48LlhuWPI3lLi4cXVMKEsGGhpIYXHTsvpheKULnq3opQEX76ZEUVFSKBAJMgHQnCY8wBtJXay5Q44y3iXqxFoPAlRRhLKIqzcdj_wsps6-4JJRKXcxcU1otft9hROtbDn1Xi70uun1xKIR37YfcTHjNquV7Xe-zqNWVqpWAzGBeNQ3P_TErseRXJZDInGbcmcr2uVrNeFy9tsaR_tpSCacG4WSLTPgsCs17SmYc2I3EuTleH_g436nxwFGwaixGv9w5I_JVp6S5rvRt545T7s6vcq9DM60s26phn0CaPx8uEUh8sHVKPMvI4jMpfuxyo3IH1NswOAxsDk5M2EK99J_BnC-uv4NIMOft0WZ-rBtMqfcvYyBNKwXbPr-zP3ps6Hj3vPh-yqe3hQhs6PIqR4U8j9cn0-bK93PX8cYdQP6pr4jyfmsynSB_TDLYiBO1iU9V8GdLaDKaM3bxuvmee32f-33VfUJtEMLjE6GL18lpzeCRpE4iTIQ2zLwOaPIxwbVudG40u4xjCsWVxPZU26cHio4x841NxHAsXJDDzfkz38K3LbX_LJxhpP3WHaq1xdrARXnVulIRODp0Oh-bkeIN3IiDiBghYMP5nn-d5rQ7vmKw8r2KxsB5M_FzsaMndUkCcE_669wWeKRNermCR8cbOFh3fiHwOMy9hC6wAA8ue83b7iqT11eiE5StWYIaEaZa3dL9gS7LUf2LPUR34aytG9-YHTkpPWui40l5sbrZ2JpU-x2ywFku2lU4FgmJrIUgJwaVwm7EajsxI_YGenBVUoLZb1aXTaapjyiYQmVZs1K4Lp7TijaUz5a41eSpjonqA2whn5rnV4SToAYQEHXFCE5-3jWSOq-UTr5Fgf44v0JTQJq1hIn2Z3lU7gUBUizN5mwWoWST-DjKwc9RM2UyOXIEhrscfZ5O6WGl7h-Ebwhq0CgaGV8ea6pFlVTqDelZ8YoWWSjI.%26dur%3D1~KLUv_WMFoCgkngCFAwD0BEsKB3dkbHh6OW8Q1tEDIjwI6IXduCxISDVVRXZXMTFJTDRsQXBraUptSlN4TnUwTzMwZTIrVVh4Q0pReGRmcUM0PdbRAzI4A0ABTaWjuj8J_Nrs2lV1jX3q-JHL0SWhXcqsv3zPxkqQqA_l8B0D%26durs%3DAQqUbh%26bdc%3D131%26uidd%3DYjDQq9greB8k-oenIzEmO2dwDDjmrMm8WUNIn6H8CxkQDDb3%26idl%3DXY30074B-kb6EwRmASpHBM1iDhxS5Jew-D3QYiGR5H6EFle58%26testid%3Diavc1%2520%26fpa%3D489%26pcm%3D3%26ict%3DWiFi%26said%3Ddeabba6c-d181-4865-afc3-7788bcccbc04%26auct%3D1%26tail%3D1%26r%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=Ndo4cz*g7O;gcsr=m;stc=1;chaa=1;sttr=37;prcl=s106.67
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://pixel.adsafeprotected.com/rjss/st/2064289/79600518/skeleton.js?ias_advertiserId=869dc5w&ias_campId=qioozay&ias_placementId=4grozau&ias_creativeId=e5txnbrf&ias_chanId=kargo&ias_pubId=8727&bidurl=mail.aol.com%2f&ias_impId=cb9a5347-7f9e-47d5-92d1-e52ad2cf2d3e&ias_dealId=&ias_xappb=mail.aol.com&ias_dspID=9&adsafe_par63.39
    https://fw.adsafeprotected.com/rjss/st/2432004/86461865/skeleton.js?bundleid=INSERTMACROHERE62.23
    https://s0.2mdn.net/sadbundle/7296434160257979971/2025_Carvykti_Eligible-v2_300x600_HTML5%20Banner_cp-469260v1_MA/bg.jpg60.85
    https://s0.2mdn.net/sadbundle/7296434160257979971/2025_Carvykti_Eligible-v2_300x600_HTML5%20Banner_cp-469260v1_MA/bg2.jpg60.64

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2Creative Screenshot 3